Studies reinforce Nanobac's technology
This article was originally published in Clinica
Executive Summary
Positive results from a kidney stone study could boost the profile of Nanobac Pharmaceuticals' nanobacteria-based diagnostics for detecting calcifying nanoparticles (CNPs).